Pharmaceutical

Moderna mpox mRNA vaccine shows early promise in monkey...

Moderna is currently running a Phase I/II trial of the mRNA mpox vaccine mRNA-17...

eGenesis scoops $191m for genetically modified pig kidn...

eGenesis conducted the first-in-human porcine kidney transplant earlier this yea...

Skyline wins orphan drug designation for retinitis pigm...

There are currently no approved treatments that can halt or reverse photorecepto...

UK NHS launches vaccine programme for RSV

The UK NHS has commenced its first-ever vaccination programme for RSV vaccine, t...

Simcere Zaiming and TargetRx agree TGRX-326 commercial ...

Simcere Zaiming has entered a collaboration deal with Shenzhen TargetRx to bring...

Why the Importer of Record (IoR) is vital in the clinic...

In clinical supplies, the Importer of Record (IoR) provides a critical service i...

Syntekabio and Enamine partner for AI-based drug develo...

Syntekabio has entered a partnership with Enamine for supply, synthesis of compo...

ESC 2024: Beta blocker treatment paradigm shifts for my...

New data provides more evidence on choosing the ideal approach for prescription ...

UAE MoHAP and Novo Nordisk partner for obesity management

The UAE has partnered with Novo Nordisk Pharma Gulf to develop a national scient...

FDA grants fast track status to Innovent’s IBI363 for m...

The US Food and Drug Administration (FDA) has granted fast track designation to ...

RegenxBio touts positive data for rare disease drug RGX...

RGX-121 has been evaluated in the Phase I/II/III CAMPSIITE study as a one-time g...

Ocaliva approval in Europe withdrawn following data re-...

Advanz Pharma, Ocaliva’s manufacturer, said thousands of patients will no longer...

ESC 2024: CATHEDRAL-HF trial results have the potential...

A large proportion of chronic heart failure (HF) patients are taking suboptimal ...

Diabetes duration has minimal impact on SGLT2 inhibitor...

A meta-analysis has demonstrated consistent efficacy in heart failure outcomes w...

ESC 2024: Study highlights potential for Novartis to di...

There is a strong opportunity in the heart failure (HF) space for new agents tha...

Generalized Pustular Psoriasis (GPP) drugs in developme...

GlobalData tracks 6 drugs in development for Generalized Pustular Psoriasis (GPP...